Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2000

View Archived Issues

Orion highlights R&D developments for 1999

Immunomedics successfully delivers cancer drug through bispecific fusion proteins

ML Laboratories makes offers to acquire Cobra Therapeutics

VaxGen highlights significant events in Q4 1999

Taro begins phase I testing of proprietary anticonvulsant

Cinnamamide: a lead compound for the design of structurally unique MMP inhibitors

SciClone's Zadaxin boosts immune recognition of tumor cells

UroGenesys and Protein Pathways form alliance

HemispheRx Biopharma seeks patents for HIV gene therapy

Calcium antagonists and glutamate release inhibitors in development at Eisai

New antitumor compounds from Shionogi act on ras-mediated cell signaling

Wealth of preclinical, clinical data on desloratadine presented at AAAAI meeting

Warner-Lambert patents reduced dipeptide N-type Ca2+ channel blockers

U.S. university researchers synthesize new series of PPARgamma agonists

Piperazine derivatives synthesized at Samjin exert potent antitumor activity with low toxicity

New 5alpha-reductase inhibitors in the pipeline at Kotobuki

AAAAI presentations on efficacy of E25 in asthma and seasonal allergic rhinitis

NIAID researchers describe antiscrapie compounds with promising activity in preclinical models

Lead structure for the design of tissue-selective ER ligands discovered at Novo Nordisk

AC-326-alpha, a new phosphoglycolipid antibiotic of the moenomycin group

DuPont and Aventis form discovery and development alliance

FDA approves ReFacto for hemophilia A

Effects of NO-1886 on lipid levels and LPL activity in WHHL rabbits

MetaPhore targets pain as the first indication for lead SOD mimetic

Positive developments reported at AAAAI meeting for IL-9 antibody with potential in asthma

Patent broadens protection for Endorex's oral/mucosal drug delivery system

NeoTherapeutics' nerve regeneration platform receives further patent protection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...